TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6367366

Group type: EXPERIMENTAL
Intervention: iohexol (Omnipaque)
Number of subjects: 88
Study: 30284700

Group type: EXPERIMENTAL
Intervention: 1% FIT039 patch
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3% FIT039 patch
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 27480628

Group type: EXPERIMENTAL
Intervention: Low-dose chest computed tomography (LDCT)
Number of subjects: 232
Study: 27266803

Group type: EXPERIMENTAL
Intervention: Standard tangents (STs) or high tangents (HTs) for micrometastatic SLNs without lymphovascular system invasion, used by 115 (87.1%) respondents.
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Standard tangents (STs) and supraclavicular field (SCF) or STs and full axillary coverage (AX) without neoadjuvant chemotherapy (NAC), used by 64 (48.5%) respondents.
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Supraclavicular field (SCF) and full axillary coverage (AX) after neoadjuvant chemotherapy (NAC), used by 94 (70.7%) respondents.
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Supraclavicular field (SCF) for macrometastatic SLN involvement, preferred by 45.27% of respondents.
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Full axillary coverage (AX) for macrometastatic SLN involvement, preferred by 45.66% of respondents.
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: High tangents (HTs) for micrometastatic involvement, chosen by 43.61% of respondents.
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Use of online predictive nomograms to predict further axillary involvement, reported by 40 (27.8%) respondents.
Number of subjects: 145
Study: 24731898

Group type: EXPERIMENTAL
Intervention: Auricular acupressure (AA) using auricular plasters with magnetic pellets
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo-controlled group (AA using auricular plasters with Semen Vaccariae)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care group (AA using auricular plasters only)
Number of subjects: 99
Study: 22105826

Group type: EXPERIMENTAL
Intervention: Docetaxel and capecitabine followed by cyclophosphamide, epirubicin, and capecitabine (TX/CEX)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Docetaxel followed by cyclophosphamide, epirubicin, and fluorouracil (T/CEF)
Number of subjects: 1500
Study: 21305906

Group type: EXPERIMENTAL
Intervention: Acute marijuana use
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 70
Study: 17437876

Group type: EXPERIMENTAL
Intervention: Passive ultrasonic irrigation using fluted files for 3 minutes
Number of subjects: 85

Group type: COMPARATOR
Intervention: Passive ultrasonic irrigation using nonfluted finger spreaders for 1 minute
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Passive ultrasonic irrigation using fluted files for 1 minute
Number of subjects: 85

Group type: COMPARATOR
Intervention: Passive ultrasonic irrigation using nonfluted finger spreaders
Number of subjects: 85
Study: 15561737

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg subcutaneously twice weekly
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 26
Study: 17058761

Group type: EXPERIMENTAL
Intervention: Bar-clip attachments
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ball-socket attachments
Number of subjects: 18

Group type: COMPARATOR
Intervention: Magnet attachments
Number of subjects: 18

Group type: COMPARATOR
Intervention: New lower denture without attachments
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Overall satisfaction on VAS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Maximum bite force
Number of subjects: 18
Study: 10877193

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC) infusion (5 mg/kg BW priming bolus and 0.025, 0.1, or 1.0 mg/kg BW/min constant infusion)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC) infusion
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8896005

Group type: EXPERIMENTAL
Intervention: 1 mL/kg of 0.25% bupivacaine with 1:200,000 epinephrine at a rate of 1 mL/s (subgroup A)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 1 mL/kg of 0.25% bupivacaine with 1:200,000 epinephrine at a rate of 1 mL per 10 s (subgroup B)
Number of subjects: 79
Study: 1999752

Group type: EXPERIMENTAL
Intervention: Tutorial + Prompt
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Tutorial Only
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Prompt Only
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Tutorial + Prompt, Tutorial Only, Prompt Only
Number of subjects: 261
Study: 6644094

Group type: EXPERIMENTAL
Intervention: UVA + visible radiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visible light alone
Number of subjects: 0
Study: 30720443

Group type: EXPERIMENTAL
Intervention: D‐ADM
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study: 28836462

Group type: EXPERIMENTAL
Intervention: 2-anchor repair technique
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (no repair)
Number of subjects: 9
Study: 25970541

Group type: EXPERIMENTAL
Intervention: Intra‐epidermal electrical stimulation (IES)
Number of subjects: 196
Study: 24242191

Group type: EXPERIMENTAL
Intervention: Microsurgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stereotactic technique
Number of subjects: 100
Study: 22726802

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice daily for 7 days
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice daily for 14 days
Number of subjects: 248
Study: 21044308

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: COMPARATOR
Intervention: Healthy non-AR controls
Number of subjects: 28
Study: 17495183

Group type: EXPERIMENTAL
Intervention: Genotypes associated with higher 2-hour plasma glucose levels (rs2073162-A, rs2073163-C, rs1155974-T)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Markers from haploblock 1 (rs5966709, rs4828037)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Markers from haploblock 1 (rs11798018)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Markers from haploblock 2 (rs2073163, rs1155794)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Markers rs2073163, rs1155794, and rs2073162
Number of subjects: 507
Study: 15263905

Group type: EXPERIMENTAL
Intervention: SLC6A4 genotype with social stressors and chronic diseases in females
Number of subjects: 1005

Group type: COMPARATOR
Intervention: SLC6A4 genotype
Number of subjects: 1005
Study: 11951802

Group type: EXPERIMENTAL
Intervention: Chicago IV gold alloy superstructures
Number of subjects: 26

Group type: COMPARATOR
Intervention: Palliag M silver-palladium alloy superstructures
Number of subjects: 26
Study: 10419078

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily for 4 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg once daily for 4 weeks
Number of subjects: 60
Study: 7576427

Group type: EXPERIMENTAL
Intervention: PARTY-PLUS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (light mineral water)
Number of subjects: 0
Study: 31433496

Group type: EXPERIMENTAL
Intervention: Blinatumomab
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard-of-care (SOC) chemotherapy
Number of subjects: 97
Study: 28884268

Group type: EXPERIMENTAL
Intervention: Parenting intervention for families of preschoolers at risk for conduct problems
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 99
Study: 26747438

Group type: EXPERIMENTAL
Intervention: True bifurcation lesions (TBL) treated with second-generation drug-eluting stents (DES)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Non-true bifurcation lesions (non-TBL) treated with second-generation drug-eluting stents (DES)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Patients with TBL and non-TBL
Number of subjects: 287
Study: 26225004

Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pregabalin (PGB) with Carbamazepine (CBZ)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Lamotrigine (LTG) with Carbamazepine (CBZ)
Number of subjects: 22
Study: 22721577

Group type: EXPERIMENTAL
Intervention: Financial incentives and Internet-based counseling
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 800
Study: 19744507

Group type: EXPERIMENTAL
Intervention: Electronic TV time monitor for 6 weeks with advice to restrict TV watching to 1 hour per day or less
Number of subjects: 29

Group type: COMPARATOR
Intervention: Verbal advice to restrict TV watching
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 17515743

Group type: EXPERIMENTAL
Intervention: Low-intensity intramuscular electrostimulation applied to the myofascial trigger point (MTP) with an interstimulus interval of 0.5 s.
Number of subjects: 24
Study: 15338221

Group type: COMPARATOR
Intervention: Control subjects (n=12)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: UEMSD cases without cold hands (n=10)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: UEMSD cases with cold hands (n=6)
Number of subjects: 28
Study: 11675834

Group type: EXPERIMENTAL
Intervention: Oral anticoagulant treatment (maintaining INR between 2.0 and 3.0)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin or other antiplatelet agents
Number of subjects: 0
Study: 9711469

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 7974947

Group type: EXPERIMENTAL
Intervention: Yohimbine (15 mg per day orally) and trazodone (50 mg per day orally)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Yohimbine and trazodone
Number of subjects: 63
Study: 3198868

Group type: EXPERIMENTAL
Intervention: Sinusoids of fixed frequency whose level was swept up or down by 5 or 10 dB
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Sinusoids of fixed level whose frequency was swept up or down by 100 Hz
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Sinusoids whose level was swept up or down by 10 dB and whose frequency was swept up or down by 100 Hz
Number of subjects: 4

Group type: COMPARATOR
Intervention: Fixed signal (sinusoids fixed in frequency and level)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Rate of change in frequency and/or level
Number of subjects: 4
Study: 4609555

Group type: EXPERIMENTAL
Intervention: 95% alcoholic chlorhexidine (0.5%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetrabrom‐o‐methyl phenol (0.1%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 95% alcoholic chlorhexidine (0.5%) after six treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetrabrom‐o‐methyl phenol (0.1%) after six treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4% chlorhexidine detergent solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: 95% or 70% ethyl alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aqueous 0.5% chlorhexidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcoholic chlorhexidine vs. tetrabrom‐o‐methyl phenol
Number of subjects: 0

Group type: COMPARATOR
Intervention: 70% ethyl alcohol
Number of subjects: 0
Study: 31523754

Group type: EXPERIMENTAL
Intervention: Behavioral outcomes from pooled dataset
Number of subjects: 1974

Group type: EXPERIMENTAL
Intervention: Substance use behaviors from pooled dataset
Number of subjects: 1974

Group type: EXPERIMENTAL
Intervention: STI acquisition from pooled dataset
Number of subjects: 1974
Study: 31060644

Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Duration of opioid use
Number of subjects: 36
Study: 28167196

Group type: EXPERIMENTAL
Intervention: Modified Pilates exercises, three times a week for eight weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no Pilates intervention)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intervention group (Pilates)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison between control and intervention groups after intervention
Number of subjects: 50
Study: 24124665

Group type: EXPERIMENTAL
Intervention: Tilt angle 60°
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Tilt angle 70°
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Tilt angle 80°
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Tilt angles 60°, 70°, and 80°
Number of subjects: 174
Study: 24183707

Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cognitive Training (Control)
Number of subjects: 150
Study: 21457084

Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic ureterolithotomy (RLU) without stent placement (Group 1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Retroperitoneal laparoscopic ureterolithotomy (RLU) with stent placement (Group 2)
Number of subjects: 104
Study: 18642974

Group type: EXPERIMENTAL
Intervention: 50 mg long-acting risperidone administered intramuscularly once a month
Number of subjects: 7
Study: 17003713

Group type: EXPERIMENTAL
Intervention: Tonsillotomy (TT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Total tonsillectomy (TE)
Number of subjects: 92
Study: 14559073

Group type: EXPERIMENTAL
Intervention: Severe envenomation with MOD
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Mild envenomation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All victims (severe and mild)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Severely envenomed children with MOD
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Case fatality rate
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: LODS score
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: sFas and Bcl‐2
Number of subjects: 46
Study: 10801241

Group type: EXPERIMENTAL
Intervention: Alprazolam with low-dose ritonavir (200 mg, four doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8653994

Group type: EXPERIMENTAL
Intervention: Oral contraceptive steroids
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-users of oral contraceptive steroids
Number of subjects: 12
Study: 1728021

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV) only
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: HFOV for 72 hours followed by CV (HFOV/CV)
Number of subjects: 83
Study: 6144975

Group type: EXPERIMENTAL
Intervention: Aspirin (ASA, 100 mg daily)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 30248030

Group type: EXPERIMENTAL
Intervention: Suboccipital muscle inhibition (SMI) technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cranio-cervical flexion exercise (CCFE)
Number of subjects: 20
Study: 27733107

Group type: EXPERIMENTAL
Intervention: Mizoribine (12 mg/kg/d)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (2000 mg/d)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 83
Study: 24435069

Group type: EXPERIMENTAL
Intervention: Shoe advice leaflet
Number of subjects: 57

Group type: COMPARATOR
Intervention: No leaflet (control group)
Number of subjects: 57
Study: 23039171

Group type: EXPERIMENTAL
Intervention: Imatinib mesylate 400 mg daily for 6 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 20129738

Group type: EXPERIMENTAL
Intervention: 20 mg hydrocortisone (cortisol group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (placebo group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cortisol group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 48
Study: 18601750

Group type: EXPERIMENTAL
Intervention: True auriculopressure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo auriculopressure
Number of subjects: 0
Study: 15243564

Group type: EXPERIMENTAL
Intervention: Asymptomatic unilateral tonsillar enlargement
Number of subjects: 104

Group type: COMPARATOR
Intervention: Symmetric tonsils (control group)
Number of subjects: 104
Study: 12567797

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT), 12 sessions
Number of subjects: 38

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 38
Study: 9425916

Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy
Number of subjects: 81
Study: 8125726

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg every 6 hours
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo every 6 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2486583

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine at 20 ml/hr (25 mg/hr)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine at 10 ml/hr (25 mg/hr)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 50 mg bupivacaine loading dose followed by 25 mg/hr
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Supplemental boluses of 4 ml of 0.5% bupivacaine
Number of subjects: 23
Study: 153729

Group type: EXPERIMENTAL
Intervention: iodochlorhydroxyquin-hydrocortisone cream
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: iodochlorhydroxyquin cream
Number of subjects: 354

Group type: COMPARATOR
Intervention: hydrocortisone
Number of subjects: 354

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 354
Study: 31604130

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) and primaquine (PQ) treatment (3-day CQ and 14-day PQ at 3.5 mg/kg total dose) as directly observed therapy
Number of subjects: 281
Study: 28974462

Group type: EXPERIMENTAL
Intervention: Problem-solving intervention for family members of hospice patients
Number of subjects: 73

Group type: COMPARATOR
Intervention: Adult family home setting
Number of subjects: 73
Study: 26294102

Group type: EXPERIMENTAL
Intervention: Argon laser peripheral iridoplasty (ALPI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 30
Study: 24627405

Group type: EXPERIMENTAL
Intervention: Domain-based language training for 6 months
Number of subjects: 728

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 728

Group type: COMPARATOR
Intervention: Baseline study group (no intervention)
Number of subjects: 728
Study: 23744591

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTx)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conservative follow-up
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (age- and sex-matched)
Number of subjects: 24
Study: 20010120

Group type: EXPERIMENTAL
Intervention: HOT (40 degrees C, 25% RH)
Number of subjects: 8

Group type: COMPARATOR
Intervention: TEMP (21 degrees C, 50% RH)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both environments
Number of subjects: 8
Study: 18188753

Group type: EXPERIMENTAL
Intervention: Telephone-support group (n = 118)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Self-help-only group (n = 110)
Number of subjects: 228
Study: 16163445

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB)
Number of subjects: 829

Group type: COMPARATOR
Intervention: Standard axillary treatment (level I‐III axillary lymph node dissection or four node sampling)
Number of subjects: 829
Study: 14551846

Group type: EXPERIMENTAL
Intervention: Dorsal fusion with fixateur intern and autologous bone (74 patients)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Combined dorso-ventral fusion with intervertebral fusion and tricortical autologous bone (23 patients)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Oswestry score for clinical outcome
Number of subjects: 97
Study: 10924613

Group type: EXPERIMENTAL
Intervention: 15-loci STR panel
Number of subjects: 126

Group type: COMPARATOR
Intervention: Random pairs
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Sibling group
Number of subjects: 126

Group type: COMPARATOR
Intervention: Random group
Number of subjects: 126

Group type: COMPARATOR
Intervention: Unrelated pairs
Number of subjects: 126
Study: 8830942

Group type: EXPERIMENTAL
Intervention: Transient (phasic) bell-shaped VESTEP recorded during backward-tilts in Earth-bound laboratory conditions.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sustained (tonic) negativity found during nose-down tilts in Earth-bound conditions.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Transient bell-shaped responses recorded in microgravity irrespective of tilt direction.
Number of subjects: 90
Study: 1339126

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide-containing toothpaste (0.67% hydrogen peroxide and 5.48% sodium bicarbonate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fluoride control paste (standard silica based toothpaste containing 1500 ppm F as sodium monofluorophosphate)
Number of subjects: 10
Study: 6738835

Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 30107241

Group type: EXPERIMENTAL
Intervention: Internet-delivered exposure therapy (iExp)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 140
Study: 29522919

Group type: EXPERIMENTAL
Intervention: Mechanomyography (MMG) ratio
Number of subjects: 10
Study: 25891265

Group type: EXPERIMENTAL
Intervention: Target depicted as lacking moral status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target depicted as high in morality
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition with no information about the target's moral qualities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Information on another evaluative dimension (competence)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social targets perceived as lacking moral qualities
Number of subjects: 0
Study: 24648506

Group type: EXPERIMENTAL
Intervention: Amoxicillin thrice daily (50 mg/kg/day)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Amoxicillin twice daily (50 mg/kg/day)
Number of subjects: 820